BRD2 and breast cancer: We detected a high number of somatic mutations shared among BC tumor tissues and paired NAT samples (Figure S6a and data not shown), raising concerns, in agreement with previous reports [14,15,16,17], about the use of normal-appearing adjacent-to-tumor tissues as a reference for healthy control tissue.